CollabRx and OncoDNA Partner in Molecular Diagnostics
04 avr. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, April 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and OncoDNA, SA, a Belgium...
CollabRx Forms Pan Cancer Molecular Oncology Editorial Board
26 mars 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, March 26, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced the...
CollabRx(TM) and Projects In Knowledge(R) Partner to Provide Decision Support Tools to Oncologists
04 mars 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, March 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Projects In Knowledge,...
CollabRx Forms Editorial Board for Prostate Cancer
19 févr. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 19, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the formation of an editorial board for prostate cancer to be led by E. David Crawford, M.D. who will...
CollabRx Reports Q3 Fiscal Year 2013 Financial Results
12 févr. 2013 16h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the Third Quarter Fiscal Year 2013, which ended December 31,...
CollabRx Releases Second Generation Lung Cancer Clinical Decision Support Tool for Oncologists
07 févr. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 7, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the release of a new version of its Therapy Finder™application ("app") for lung cancer. The lung...
CollabRx Schedules Q3 Fiscal Year 2013 Financial Conference Call and Business Update
05 févr. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February...